Determination of Active Ingredients in Pesticide Emulsifiable Concentrates (EC): Methods, Standards,

Accurate determination of active ingredient content is the single most critical quality parameter for pesticide emulsifiable concentrates (EC), directly governing biological efficacy, regulatory compliance, and conformity with label declarations. This article presents a comprehensive technical overview of EC sample types, testing items, chromatographic and classical analytical methods, applicable standards such as GB and CIPAC procedures, and the quality controls required for reliable quantification in accredited third-party laboratories.

Technical Overview

An emulsifiable concentrate (EC) is a homogeneous liquid pesticide formulation consisting of a technical-grade active ingredient dissolved in an organic solvent system together with emulsifiers, which spontaneously forms a stable emulsion when diluted with water in the field. Because the solvent and surfactant components carry no biological activity, the declared amount of active ingredient—typically expressed as grams per liter (g/L at 20 °C) or percent by mass (% m/m)—is the defining specification of the product.

Determination of the active ingredient verifies that a manufactured or marketed EC batch falls within the tolerance range established by the relevant national standard (GB or HG), FAO/WHO specification, or the registered product label. Quantification is performed almost exclusively by chromatographic techniques, using a certified reference material (CRM) of known purity and an external standard calibration model. The result underpins batch release decisions, registration dossiers, import–export verification, and market surveillance against counterfeit or under-strength products.

Testing Samples

Commercial EC Formulations

Routine submissions include finished EC products covering all major insecticide and acaricide classes:

• Organophosphates: chlorpyrifos EC, phoxim EC, triazophos EC, dimethoate EC
• Pyrethroids: lambda-cyhalothrin EC, beta-cypermethrin EC, bifenthrin EC, fenpropathrin EC
• Avermectins and others: abamectin EC, emamectin benzoate EC, dicofol EC, carbosulfan EC

Technical-Grade Active Ingredients and Formulation Intermediates

Technical materials and pre-formulation concentrates are tested before compounding to confirm incoming purity, since any deficit in the starting material propagates directly into the finished EC content.

Registration and Market Surveillance Samples

Samples collected for product registration dossiers, five-batch analysis, or regulatory spot checks are tested against the declared label content and applicable specification tolerances.

Stability and Shelf-Life Study Samples

Samples taken before and after accelerated storage testing (typically 14 days at 54 °C per CIPAC MT 46.3) and low-temperature stability testing are assayed to quantify active ingredient recovery and degradation over the claimed shelf life.

Testing Items

The core determination package for EC products typically includes:

• Active ingredient content, reported as % (m/m) and/or g/L at 20 °C
• Isomer composition (for example, cis/trans ratios of pyrethroids such as beta-cypermethrin), where the biological activity is isomer-dependent
• Relevant impurities and degradation products associated with the manufacturing route
• Supporting specification parameters frequently assayed alongside the active content: water content (Karl Fischer, CIPAC MT 30 / GB/T 1600), acidity or alkalinity (CIPAC MT 31 / GB/T 1601), emulsion stability (CIPAC MT 36 / GB/T 1603), and persistent foam (CIPAC MT 47)

Testing Methods

Sample Preparation

A representative sample is drawn per the sampling procedure for commercial pesticides (GB/T 1605). A accurately weighed portion of the homogenized EC (typically 0.05–0.2 g) is diluted to volume with a suitable solvent such as acetonitrile, methanol, or a mobile-phase-compatible mixture, vortexed or sonicated to ensure complete dissolution, and filtered through a 0.45 µm (or 0.22 µm) membrane into the autosampler vial. Duplicate or triplicate preparations per sample are standard practice.

High Performance Liquid Chromatography (HPLC-UV/DAD)

HPLC is the primary method for thermally labile or non-volatile actives, including pyrethroids, abamectin, and emamectin benzoate. Typical conditions employ a reversed-phase C18 column, an isocratic or gradient methanol/water or acetonitrile/water mobile phase, a flow rate near 1.0 mL/min, and UV or diode-array detection at a validated wavelength (for example, 220–254 nm depending on the compound). Diode-array spectral confirmation additionally verifies peak purity.

Gas Chromatography (GC-FID)

GC with flame ionization detection is preferred for volatile, thermally stable actives such as many organophosphates. A capillary column with a low-polarity phase (for example, 5% phenyl-methylpolysiloxane), split injection, and an optimized temperature program provide separation of the active ingredient from solvent, co-formulants, and impurities. Selective detectors (NPD or FPD) may be used for phosphorus- or sulfur-containing actives to enhance specificity.

Confirmatory and Complementary Techniques

• GC-MS and LC-MS/MS: mass-spectrometric confirmation of identity and quantification of trace-level impurities or degradation products
• Titrimetric and gravimetric methods: applied where a stoichiometric functional group exists and validated classical methods are available in the relevant standard
• Density measurement (pycnometer or digital densitometer at 20 °C): required to convert between % (m/m) and g/L reporting bases

Calibration and Quantification

Quantification follows the external standard method against a certified reference material of documented purity and traceability. The active ingredient content is calculated by comparing the peak area of the sample solution with that of the standard solution, corrected for standard purity, weighing, and dilution factors. System suitability criteria—resolution, peak tailing, theoretical plates, and replicate injection precision (area RSD typically ≤2%)—must be satisfied before sequence data are accepted.

Method Validation and Quality Control

Methods are validated for specificity, linearity (correlation coefficient typically r ≥ 0.999 across at least five calibration levels), accuracy (recovery generally within 98–102% for formulation-level assay), and precision (repeatability RSD typically ≤2%). Laboratories operating under an ISO/IEC 17025 quality management system apply controlled documents, bracketing standard checks, and control charts to monitor batch-to-batch performance, with an estimated expanded measurement uncertainty commonly in the range of 1–2% relative.

Applications

• Manufacturing quality control and batch release of EC production lines
• Registration dossiers, including five-batch analysis and equivalence support data
• Import and export conformity verification against national standards and FAO/WHO specifications
• Market surveillance, counterfeit identification, and dispute resolution
• Accelerated and long-term storage stability studies supporting shelf-life claims
• Research and development of new formulations and generic product development

FAQ

Why can results be reported as both % (m/m) and g/L?

Mass percent is independent of temperature, while g/L at 20 °C is the customary declaration basis for liquid formulations in many specifications. Conversion between the two requires the measured density of the product at 20 °C, which is why density determination is an integral part of the assay package.

How are acceptance tolerances applied?

The measured content must fall within the tolerance stated in the applicable national standard or FAO/WHO specification. Tolerances widen as the declared content decreases, so a low-concentration EC such as a 1.8% abamectin EC permits a proportionally wider band than a high-concentration product such as a 40% chlorpyrifos EC.

What happens if HPLC and GC results disagree?

Discrepancies usually indicate co-elution with formulation components, on-column degradation, or incomplete extraction. The investigation includes peak purity assessment by DAD or MS, alternate-column confirmation, and review of sample preparation, followed by re-assay with a validated orthogonal method.

How much sample is required and what is the typical turnaround?

Approximately 50–100 mL of homogenized EC product is sufficient for duplicate determination plus retained sample. Routine active ingredient assay is generally completed within 5–10 working days in accredited third-party laboratories, subject to queue and confirmatory testing requirements.

Why is water content tested alongside the active ingredient?

Excess water in an EC can hydrolyze susceptible actives—particularly organophosphates—accelerate degradation during storage, and destabilize the emulsion upon dilution. Monitoring water content therefore protects both the assay result and the product specification.